Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI)

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18682-18710

  Du, Yimeng ^a   Lai, Pui To ^a   Leung, Cheung Hoi ^a   Pong, Philip W T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Medical imaging; MPI; Superparamagnetic nanoparticles

Indexed keywords

FERUCARBOTRAN; IODINATED CONTRAST MEDIUM; MAGNETIC NANOPARTICLE; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CELL LABELING; CELL TRACKING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION ROUTE; DRUG SAFETY; ERYTHROCYTE; HUMAN; IMAGE QUALITY; IMAGE RETRIEVAL; IMMUNOCOMPETENT CELL; MAGNETIC FIELD; MAGNETIC PARTICLE IMAGING; MAGNETIC RESONANCE ANGIOGRAPHY; MELANOMA; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OPTICAL RESOLUTION; PERFORMANCE MEASUREMENT SYSTEM; PROSTATE CANCER; REVIEW; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; THREE DIMENSIONAL IMAGING; UNSPECIFIED SIDE EFFECT;

DIAGNOSTIC IMAGING; MAGNETICS; NANOPARTICLES;

EID: 84884176588     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918682     Document Type: Review

References (151)

1. Gleich, B.; Weizenecker, J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005, 435, 1214-1217.
2. Knopp, T.; Buzug, T.M. Introduction. In Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation; Springer Berlin Heidelberg: Berlin, Germany, 2012; pp. 1-9.
3. Ferguson, R.M.; Minard, K.R.; Krishnan, K.M. Optimization of nanoparticle core size for magnetic particle imaging. J. Magn. Magn. Mater. 2009, 321, 1548-1551.
4. Krishnan, K.M.; Pakhomov, A.B.; Bao, Y.; Blomqvist, P.; Chun, Y.; Gonzales, M.; Griffin, K.; Ji, X.; Roberts, B.K. Nanomagnetism and spin electronics: Materials, microstructure and novel properties. J. Mater. Sci. 2006, 41, 793-815.
5. Bedanta, S.; Kleemann, W. Supermagnetism. J. Phys. D: Appl. Phys. 2009, 42, 013001:1-013001:28.
6. Herrera, A.P.; Barrera, C.; Zayas, Y.; Rinaldi, C. Monitoring colloidal stability of polymer-coated magnetic nanoparticles using AC susceptibility measurements. J. Colloid. Interf. Sci. 2010, 342, 540-549.
7. Capadona, J.R.; Shanmuganathan, K.; Tyler, D.J.; Rowan, S.J.; Weder, C. Stimuli-responsive polymer nanocomposites inspired by the sea cucumber dermis. Science 2008, 319, 1370-1374.
8. Zhang, J.; Misra, R.D.K. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater. 2007, 3, 838-850.
9. Zhang, J.L.; Srivastava, R.S.; Misra, R.D.K. Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: Synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir 2007, 23, 6342-6351.
10. Bronstein, L.M.; Huang, X.; Retrum, J.; Schmucker, A.; Pink, M.; Stein, B.D.; Dragnea, B. Influence of iron oleate complex structure on iron oxide nanoparticle formation. Chem. Mater. 2007, 19, 3624-3632.
11. Briley-Saebo, K.; Bjørnerud, A.; Grant, D.; Ahlstrom, H.; Berg, T.; Kindberg, G.M. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: Implications for magnetic resonance imaging. Cell Tissue Res. 2004, 316, 315-323.
12. Clement, J.H.; Schwalbe, M.; Buske, N.; Wagner, K.; Schnabelrauch, M.; Gornert, P.; Kliche, K.O.; Pachmann, K.; Weitschies, W.; Hoffken, K. Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells. J. Cancer. Res. Clin. 2006, 132, 287-292.
13. Khandhar, A.P.; Ferguson, R.M.; Simon, J.A.; Krishnan, K.M. Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia. J. Biomed. Mater. Res. A 2012, 100A, 728-737.
14. Alexiou, C.; Jurgons, R.; Seliger, C.; Brunke, O.; Iro, H.; Odenbach, S. Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting. Anticancer Res. 2007, 27, 2019-2022.
15. Reimer, P.; Tombach, B. Hepatic MRI with SPIO: Detection and characterization of focal liver lesions. Eur. Radiol. 1998, 8, 1198-1204.
16. Grubnic, S.; Padhani, A.R.; Revell, P.B.; Husband, J.E. Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging. Am. J. Roentgenol. 1999, 173, 173-178.
17. Mitchell, D.G. MR imaging contrast agents-What's in a name? J. Magn. Reson. Imaging 1997, 7, 1-4.
18. Saritas, E.U.; Goodwill, P.W.; Croft, L.R.; Konkle, J.J.; Lu, K.; Zheng, B.; Conolly, S.M. Magnetic particle imaging (MPI) for NMR and MRI researchers. J. Magn. Reson. 2013, 229, 116-126.
19. Borgert, J.; Schmidt, J.D.; Schmale, I.; Rahmer, J.; Bontus, C.; Gleich, B.; David, B.; Eckart, R.; Woywode, O.; Weizenecker, J., et al. Fundamentals and applications of magnetic particle imaging. J. Cardiovasc. Comput. Tomogr. 2012, 6, 149-153.
20. Weizenecker, J.; Borgert, J.; Gleich, B. A simulation study on the resolution and sensitivity of magnetic particle imaging. Phys. Med. Biol. 2007, 52, 6363-6374.
21. Murase, K.; Konishi, T.; Takeuchi, Y.; Takata, H.; Saito, S. Experimental and simulation studies on the behavior of signal harmonics in magnetic particle imaging. Radiol. Phys. Technol. 2013, 1-16.
22. Rahmer, J.; Weizenecker, J.; Gleich, B.; Borgert, J. Signal encoding in magnetic particle imaging: Properties of the system function. BMC Med. Imaging 2009, 9, 4:1-4:21.
23. Goodwill, P.W.; Saritas, E.U.; Croft, L.R.; Kim, T.N.; Krishnan, K.M.; Schaffer, D.V.; Conolly, S.M. X-space MPI: Magnetic nanoparticles for safe medical imaging. Adv. Mater. 2012, 24, 3870-3877.
24. Khandhar, A.P.; Ferguson, R.M.; Arami, H.; Krishnan, K.M. Monodisperse magnetite nanoparticle tracers for in vivo magnetic particle imaging. Biomaterials 2013, 34, 3837-3845.
25. Knopp, T.; Buzug, T.M. How Magnetic Particle Imaging Works. In Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation; Springer Berlin Heidelberg: Berlin, Germany, 2012; pp. 11-70.
26. Krishnan, K.M. Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans. Magn. 2010, 46, 2523-2558.
27. Knopp, T.; Biederer, S.; Sattel, T.F.; Erbe, M.; Buzug, T.M. Prediction of the spatial resolution of magnetic particle imaging using the modulation transfer function of the imaging process. IEEE Trans. Med. Imaging 2011, 30, 1284-1292.
28. Goodwill, P.W.; Tamrazian, A.; Croft, L.R.; Lu, C.D.; Johnson, E.M.; Pidaparthi, R.; Ferguson, R.M.; Khandhar, A.P.; Krishnan, K.M.; Conolly, S.M. Ferrohydrodynamic relaxometry for magnetic particle imaging. Appl. Phys. Lett. 2011, 98, 262502:1-262502:3.
29. Ferguson, R.M.; Khandhar, A.P.; Krishnan, K.M. Tracer design for magnetic particle imaging (invited). J. Appl. Phys. 2012, 111, 07B318:1-07B318:5.
30. Ferguson, R.M.; Minard, K.R.; Khandhar, A.P.; Krishnan, K.M. Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. Med. Phys. 2011, 38, 1619-1626.
31. Herrera, A.P.; Polo-Corrales, L.; Chavez, E.; Cabarcas-Bolivar, J.; Uwakweh, O.N.; Rinaldi, C. Influence of aging time of oleate precursor on the magnetic relaxation of cobalt ferrite nanoparticles synthesized by the thermal decomposition method. J. Magn. Magn. Mater. 2013, 328, 41-52.
32. Shliomis, M.I. Magnetic fluids. Sov. Phys. Uspekhi 1974, 17, 153-169.
33. Yokoyama, M.; Ohta, E.; Sato, T. Magnetic properties of ultrafine particles and bulk material of cadmium ferrite. J. Magn. Magn. Mater. 1998, 183, 173-180.
34. Chantrell, R.W.; Popplewell, J.; Charles, S.W. Measurements of particle size distribution parameters in ferrofluids. IEEE Trans. Magn. 1978, 14, 975-977.
35. Kiss, L.B.; Söderlund, J.; Niklasson, G.A.; Granqvist, C.G. New approach to the origin of lognormal size distributions of nanoparticles. Nanotechnology 1999, 10, 25-28.
36. Goodwill, P.W.; Conolly, S.M. The X-space formulation of the magnetic particle imaging process: 1-D signal, resolution, bandwidth, SNR, SAR, and magnetostimulation. IEEE Trans. Med. Imaging 2010, 29, 1851-1859.
37. Fannin, P.C. Investigating magnetic fluids by means of complex susceptibility measurements. J. Magn. Magn. Mater. 2003, 258-259, 446-451.
38. Starmans, L.W.E.; Burdinski, D.; Haex, N.P.M.; Moonen, R.P.M.; Strijkers, G.J.; Nicolay, K.; Grüll, H. Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging. PLoS One 2013, 8, e57335:1-e57335:9.
39. Weizenecker, J.; Gleich, B.; Rahmer, J.; Dahnke, H.; Borgert, J. Three-dimensional real-time in vivo magnetic particle imaging. Phys. Med. Biol. 2009, 54, L1-L10.
40. McCullough, P.A. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 2008, 51, 1419-1428.
41. Kuo, P.H.; Kanal, E.; Abu-Alfa, A.K.; Cowper, S.E. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007, 242, 647-649.
42. Katzberg, R.W.; Haller, C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int. 2006, 69, S3-S7.
43. Ix, J.H.; Mercado, N.; Shlipak, M.G.; Lemos, P.A.; Boersma, E.; Lindeboom, W.; O'Neill, W.W.; Wijns, W.; Serruys, P.W. Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS). Am. Heart J. 2005, 149, 512-519.
44. Bettmann, M.A. Frequently asked questions: Iodinated contrast agents. Radiographics 2004, 24, S3-S10.
45. Gleich, B.; Weizenecker, J.; Borgert, J. Experimental results on fast 2D-encoded magnetic particle imaging. Phys. Med. Biol. 2008, 53, N81-N84.
46. Laconte, L.; Nitin, N.; Bao, G. Magnetic nanoparticle probes. Mater. Today 2005, 8, 32-38.
47. Neuwelt, E.A.; Hamilton, B.E.; Varallyay, C.G.; Rooney, W.R.; Edelman, R.D.; Jacobs, P.M.; Watnick, S.G. Ultrasmall superparamagnetic iron oxides (USPIOs): A future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 2009, 75, 465-474.
48. Weissleder, R.; Stark, D.D.; Engelstad, B.L.; Bacon, B.R.; Compton, C.C.; White, D.L.; Jacobs, P.; Lewis, J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am. J. Roentgenol. 1989, 152, 167-173.
49. Reimer, P.; Balzer, T. Ferucarbotran (resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur. Radiol. 2003, 13, 1266-1276.
50. Lu, M.; Cohen, M.H.; Rieves, D.; Pazdur, R. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am. J. Hematol. 2010, 85, 315-319.
51. Maddux, J.; Chen, S.; Groves, B.; Messenger, J.; Wink, O.; Carroll, J. Rotational angiography and 3D coronary modeling: Revolutions in the cardiac cath lab. MedicaMundi 2003, 47, 8-14.
52. Almeida, J.P.M.; Chen, A.L.; Foster, A.; Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine 2011, 6, 815-835.
53. Antonelli, A.; Sfara, C.; Manuali, E.; Bruce, I.J.; Magnani, M. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine 2011, 6, 211-223.
54. Berry, C.C.; Curtis, A.S.G. Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 2003, 36, R198-R206.
55. Fujita, T.; Nishikawa, M.; Ohtsubo, Y.; Ohno, J.; Takakura, Y.; Sezaki, H.; Hashida, M. Control of in vivo fate of albumin derivatives utilizing combined chemical modification. J. Drug Target. 1994, 2, 157-165.
56. Papisov, M.; Bogdanov, A., Jr.; Schaffer, B.; Nossiff, N.; Shen, T.; Weissleder, R.; Brady, T. Colloidal magnetic resonance contrast agents: Effect of particle surface on biodistribution. J. Magn. Magn. Mater. 1993, 122, 383-386.
57. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13, 245-255.
58. Sun, C.; Lee, J.S.H.; Zhang, M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug. Deliver. Rev. 2008, 60, 1252-1265.
59. Decuzzi, P.; Ferrari, M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 2006, 27, 5307-5314.
60. Storm, G.; Belliot, S.O.; Daemen, T.; Lasic, D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug. Deliver. Rev. 1995, 17, 31-48.
61. Chen, L.T.; Weiss, L. The role of the sinus wall in the passage of erythrocytes through the spleen. Blood 1973, 41, 529-537.
62. Choi, H.S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J.P.; Ipe, B.I.; Bawendi, M.G.; Frangioni, J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25, 1165-1170.
63. Sarin, H. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J. Angiogenes. Res. 2010, 2, 14:1-14:19.
64. Albanese, A.; Tang, P.S.; Chan, W.C.W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14, 1-16.
65. Alexis, F.; Pridgen, E.; Molnar, L.K.; Farokhzad, O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 2008, 5, 505-515.
66. Longmire, M.; Choyke, P.L.; Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine 2008, 3, 703-717.
67. Rahmer, J.; Antonelli, A.; Sfara, C.; Tiemann, B.; Gleich, B.; Magnani, M.; Weizenecker, J.; Borgert, J. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection. Phys. Med. Biol. 2013, 58, 3965-3977.
68. Markov, D.E.; Boeve, H.; Gleich, B.; Borgert, J.; Antonelli, A.; Sfara, C.; Magnani, M. Human erythrocytes as nanoparticle carriers for magnetic particle imaging. Phys. Med. Biol. 2010, 55, 6461-6473.
69. Magnani, M.; Rossi, L.; D'Ascenzo, M.; Panzani, I.; Bigi, L.; Zanella, A. Erythrocyte engineering for drug delivery and targeting. Biotechnol. Appl. Bioc. 1998, 28, 1-6.
70. Antonelli, A.; Sfara, C.; Magnani, M.; Rahmer, J.; Gleich, B.; Borgert, J.; Weizenecker, J. Red Blood Cells as Magnetic Carriers for MPI Applications. In Magnetic Particle Imaging; Buzug, T.M., Borgert, J., Eds.; Springer: London, UK, 2012; Volume 140, pp. 175-179.
71. Zink, S.I.; Ohki, S.K.; Stein, B.; Zambuto, D.A.; Rosenberg, R.J.; Choi, J.J.; Tubbs, D.S. Noninvasive evaluation of active lower gastrointestinal bleeding: Comparison between contrast-enhanced MDCT and 99mTc-labeled RBC scintigraphy. Am. J. Roentgenol. 2008, 191, 1107-1114.
72. Howarth, D.M. The role of nuclear medicine in the detection of acute gastrointestinal bleeding. Semin. Nucl. Med. 2006, 36, 133-146.
73. Zheng, J.G.; Yao, Z.M.; Shu, C.Y.; Zhang, Y.; Zhang, X. Role of SPECT/CT in diagnosis of hepatic hemangiomas. World J. Gastroentero. 2005, 11, 5336-5341.
74. Brähler, M.; Georgieva, R.; Buske, N.; Müller, A.; Müller, S.; Pinkernelle, J.; Teichgräber, U.; Voigt, A.; Bäumler, H. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. Nano Lett. 2006, 6, 2505-2509.
75. Antonelli, A.; Sfara, C.; Manuali, E.; Salamida, S.; Louin, G.; Magnani, M. SPIE Medical Imaging. In Magnetic Red Blood Cells as New Contrast Agents for MRI Applications; International Society for Optics and Photonics: Washington, USA, 2013; pp. 86721D:1-86721D:8.
76. Fayad, Z.A.; Fuster, V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ. Res. 2001, 89, 305-316.
77. Yang, J.; Yang, H.; Cao, L.; Li, S. MR and targeted molecular MRI of vulnerable plaques. Intervent. Neurol. 2012, 1, 124-131.
78. Klink, A.; Lancelot, E.; Ballet, S.; Vucic, E.; Fabre, J.E.; Gonzalez, W.; Medina, C.; Corot, C.; Mulder, W.J.M.; Mallat, Z., et al. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscl. Throm. Vas. 2010, 30, 403-410.
79. Lancelot, E.; Amirbekian, V.; Brigger, I.; Raynaud, J.S.; Ballet, S.; David, C.; Rousseaux, O.; Le Greneur, S.; Port, M.; Lijnen, H.R., et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscl. Throm. Vas. 2008, 28, 425-432.
80. Saam, T.; Cai, J.; Ma, L.; Cai, Y.Q.; Ferguson, M.S.; Polissar, N.L.; Hatsukami, T.S.; Yuan, C. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006, 240, 464-472.
81. Hansson, G.K.; Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12, 204-212.
82. Hansson, G.K.; Libby, P. The immune response in atherosclerosis: A double-edged sword. Nat. Rev. Immunol. 2006, 6, 508-519.
83. Epstein, F.H.; Ross, R. Atherosclerosis-An Inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
84. Naghavi, M.; Libby, P.; Falk, E.; Casscells, S.W.; Litovsky, S.; Rumberger, J.; Badimon, J.J.; Stefanadis, C.; Moreno, P.; Pasterkamp, G., et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II. Circulation 2003, 108, 1772-1778.
85. Faxon, D.P.; Fuster, V.; Libby, P.; Beckman, J.A.; Hiatt, W.R.; Thompson, R.W.; Topper, J.N.; Annex, B.H.; Rundback, J.H.; Fabunmi, R.P., et al. Atherosclerotic vascular disease conference: Writing group III: Pathophysiology. Circulation 2004, 109, 2617-2625.
86. Nighoghossian, N.; Derex, L.; Douek, P. The vulnerable carotid artery plaque: Current imaging methods and new perspectives. Stroke 2005, 36, 2764-2772.
87. Tang, T.Y.; Howarth, S.P.S.; Miller, S.R.; Graves, M.J.; Jean-Marie, U.K.I.; Trivedi, R.A.; Li, Z.Y.; Walsh, S.R.; Brown, A.P.; Kirkpatrick, P.J., et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: An ultra small superparamagnetic iron oxide enhanced magnetic resonance study. J. Neurol. Neurosur. Ps. 2007, 78, 1337-1343.
88. Trivedi, R.A.; Mallawarachi, C.; Jean-Marie, U.K.I.; Graves, M.J.; Horsley, J.; Goddard, M.J.; Brown, A.; Wang, L.; Kirkpatrick, P.J.; Brown, J., et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscl. Throm. Vas. 2006, 26, 1601-1606.
89. Trivedi, R.A.; Jean-Marie, U.K.I.; Graves, M.J.; Cross, J.J.; Horsley, J.; Goddard, M.J.; Skepper, J.N.; Quartey, G.; Warburton, E.; Joubert, I., et al. In vivo detection of macrophages in human carotid atheroma: Temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004, 35, 1631-1635.
90. Rogers, W.J.; Basu, P. Factors regulating macrophage endocytosis of nanoparticles: Implications for targeted magnetic resonance plaque imaging. Atherosclerosis 2005, 178, 67-73.
91. Litovsky, S.; Madjid, M.; Zarrabi, A.; Casscells, S.W.; Willerson, J.T.; Naghavi, M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 2003, 107, 1545-1549.
92. Ruehm, S.G.; Corot, C.; Vogt, P.; Kolb, S.; Debatin, J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103, 415-422.
93. Kooi, M.E.; Cappendijk, V.C.; Cleutjens, K.B.J.M.; Kessels, A.G.H.; Kitslaar, P.J.E.H.M.; Borgers, M.; Frederik, P.M.; Daemen, M.J.A.P.; van Engelshoven, J.M.A. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107, 2453-2458.
94. Metz, S.; Beer, A.J.; Settles, M.; Pelisek, J.; Botnar, R.M.; Rummeny, E.J.; Heider, P. Characterization of carotid artery plaques with USPIO-enhanced MRI: Assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int. J. Cardiovasc. Imaging 2011, 27, 901-912.
95. Jaffer, F.A.; Libby, P.; Weissleder, R. Molecular and cellular imaging of atherosclerosis: emerging applications. J. Am. Coll. Cardiol. 2006, 47, 1328-1338.
96. Nagaoka, K.; Takahara, K.; Tanaka, K.; Yoshida, H.; Steinman, R.M.; Saitoh, S.I.; Akashi-Takamura, S.; Miyake, K.; Kang, Y.S.; Park, C.G., et al. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in Gram-negative Bacteria. Int. Immunol. 2005, 17, 827-836.
97. Iida, H.; Eberl, S. Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT. J. Nucl. Cardiol. 1998, 5, 313-331.
98. Di Carli, M.F.; Dorbala, S.; Meserve, J.; El Fakhri, G.; Sitek, A.; Moore, S.C. Clinical myocardial perfusion PET/CT. J. Nucl. Med. 2007, 48, 783-793.
99. Rauwerdink, A.M.; Giustini, A.J.; Weaver, J.B. Simultaneous quantification of multiple magnetic nanoparticles. Nanotechnology 2010, 21, 455101:1-455101:5.
100. Wojtczyk, H.; Haegele, J.; Grüttner, M.; Tenner, W.; Bringout, G.; Graeser, M.; Vogt, F.M.; Barkhausen, J.; Buzug, T.M. Visualization of Instruments in interventional Magnetic Particle Imaging (iMPI): A Simulation Study on SPIO Labelings. In Magnetic Particle Imaging; Buzug, T.M., Borgert, J., Eds.; Springer: London, UK, 2012; Volume 140, pp. 167-172.
101. Haegele, J.; Rahmer, J.; Gleich, B.; Bontus, C.; Borgert, J.; Wojtczyk, H.; Buzug, T.M.; Barkhausen, J.; Vogt, F.M. Visualization of Instruments for Cardiovascular Intervention Using MPI. In Magnetic Particle Imaging; Buzug, T.M., Borgert, J., Eds.; Springer: London, UK, 2012; Volume 140, pp. 211-215.
102. Haegele, J.; Biederer, S.; Wojtczyk, H.; Gräser, M.; Knopp, T.; Buzug, T.M.; Barkhausen, J.; Vogt, F.M. Toward cardiovascular interventions guided by magnetic particle imaging: First instrument characterization. Magnet. Reson. Med. 2013, 69, 1761-1767.
103. Saxena, V.; Gonzalez-Gomez, I.; Laug, W.E. A noninvasive multimodal technique to monitor brain tumor vascularization. Phys. Med. Biol. 2007, 52, 5295-5308.
104. Mazaheri, Y.; Shukla-Dave, A.; Muellner, A.; Hricak, H. MRI of the prostate: Clinical relevance and emerging applications. J. Magn. Reson. Imaging 2011, 33, 258-274.
105. Kobayashi, H.; Kawamoto, S.; Bernardo, M.; Brechbiel, M.W.; Knopp, M.V.; Choyke, P.L. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J. Control. Release 2006, 111, 343-351.
106. Dowlatshahi, K.; Fan, M.; Snider, H.C.; Habib, F.A. Lymph node micrometastases from breast carcinoma. Cancer 1997, 80, 1188-1197.
107. Fisher, B.; Bauer, M.; Wickerham, D.L.; Redmond, C.K.; Fisher, E.R.; Cruz, A.B.; Foster, R.; Gardner, B.; Lerner, H.; Margolese, R., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983, 52, 1551-1557.
108. Goldhirsch, A.; Glick, J.H.; Gelber, R.D.; Coates, A.S.; Senn, H.J. Meeting highlights: International consensus panel on the treatment of primary breast cancer. J. Clin. Oncol. 2001, 19, 3817-3827.
109. Luciani, A.; Itti, E.; Rahmouni, A.; Meignan, M.; Clement, O. Lymph node imaging: Basic principles. Eur. J. Radiol. 2006, 58, 338-344.
110. Martínez-Palones, J.M.; Gil-Moreno, A.; Pérez-Benavente, M.A.; Roca, I.; Xercavins, J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol. Oncol. 2004, 92, 845-850.
111. Cabanas, R.M. Anatomy and biopsy of sentinel lymph nodes. Urol. Clin. North Am. 1992, 19, 267-276.
112. Jain, R.; Dandekar, P.; Patravale, V. Diagnostic nanocarriers for sentinel lymph node imaging. J. Control. Release 2009, 138, 90-102.
113. Corot, C.; Robert, P.; Idee, J.M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006, 58, 1471-1504.
114. Harisinghani, M.G.; Barentsz, J.; Hahn, P.F.; Deserno, W.M.; Tabatabaei, S.; van de Kaa, C.H.; de la Rosette, J.; Weissleder, R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl.J. Med. 2003, 348, 2491-2499.
115. Ross, R.W.; Zietman, A.L.; Xie, W.; Coen, J.J.; Dahl, D.M.; Shipley, W.U.; Kaufman, D.S.; Islam, T.; Guimaraes, A.R.; Weissleder, R., et al. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin. Imaging 2009, 33, 301-305.
116. Guimaraes, A.R.; Tabatabei, S.; Dahl, D.; McDougal, W.S.; Weissleder, R.; Harisinghani, M.G. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 2008, 71, 708-712.
117. Heesakkers, R.A.M.; Jager, G.J.; Hövels, A.M.; de Hoop, B.; van den Bosch, H.C.M.; Raat, F.; Witjes, J.A.; Mulders, P.F.A.; van der Kaa, C.H.; Barentsz, J.O. Prostate cancer: Detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology 2009, 251, 408-414.
118. Pankhurst, Q.A.; Thanh, N.T.K.; Jones, S.K.; Dobson, J. Progress in applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 2009, 42, 224001:1-224001:15.
119. Lee, J.H.; Jang, J.T.; Choi, J.S.; Moon, S.H.; Noh, S.H.; Kim, J.W.; Kim, J.G.; Kim, I.S.; Park, K.I.; Cheon, J. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 2011, 6, 418-422.
120. Carrey, J.; Mehdaoui, B.; Respaud, M. Simple models for dynamic hysteresis loop calculations of magnetic single-domain nanoparticles: Application to magnetic hyperthermia optimization. J. Appl. Phys. 2011, 109, 083921:1-083921:17.
121. Balivada, S.; Rachakatla, R.S.; Wang, H.; Samarakoon, T.N.; Dani, R.K.; Pyle, M.; Kroh, F.O.; Walker, B.; Leaym, X.; Koper, O.B., et al. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: A mouse study. BMC Cancer 2010, 10, 119:1-119:9.
122. Johannsen, M.; Gneveckow, U.; Thiesen, B.; Taymoorian, K.; Cho, C.H.; Waldofner, N.; Scholz, R.; Jordan, A.; Loening, S.A.; Wust, P. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 2007, 52, 1653-1662.
123. Hildebrandt, B.; Wust, P.; Ahlers, O.; Dieing, A.; Sreenivasa, G.; Kerner, T.; Felix, R.; Riess, H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hemat. 2002, 43, 33-56.
124. Rauwerdink, A.M.; Hansen, E.W.; Weaver, J.B. Nanoparticle temperature estimation in combined AC and DC magnetic fields. Phys. Med. Biol. 2009, 54, L51-L55.
125. Gonzales-Weimuller, M.; Zeisberger, M.; Krishnan, K.M. Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J. Magn. Magn. Mater. 2009, 321, 1947-1950.
126. Khandhar, A.P.; Ferguson, R.M.; Krishnan, K.M. Monodispersed magnetite nanoparticles optimized for magnetic fluid hyperthermia: Implications in biological systems. J. Appl. Phys. 2011, 109, 07B310:1-07B310:3.
127. Rosensweig, R.E. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 2002, 252, 370-374.
128. Kim, S.U.; de Vellis, J. Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 2009, 87, 2183-2200.
129. Hess, D.; Li, L.; Martin, M.; Sakano, S.; Hill, D.; Strutt, B.; Thyssen, S.; Gray, D.A.; Bhatia, M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 2003, 21, 763-770.
130. Jackson, K.A.; Majka, S.M.; Wang, H.; Pocius, J.; Hartley, C.J.; Majesky, M.W.; Entman, M.L.; Michael, L.H.; Hirschi, K.K.; Goodell, M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Investig. 2001, 107, 1395-1402.
131. Kim, J.H.; Auerbach, J.M.; Rodríguez-Gómez, J.A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S.H.; Nguyen, J.; Sánchez-Pernaute, R.; Bankiewicz, K., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of parkinson's disease. Nature 2002, 418, 50-56.
132. Elhami, E.; Goertzen, A.L.; Xiang, B.; Deng, J.; Stillwell, C.; Mzengeza, S.; Arora, R.C.; Freed, D.; Tian, G. Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1323-1334.
133. Bindslev, L.; Haack-Sørensen, M.; Bisgaard, K.; Kragh, L.; Mortensen, S.; Hesse, B.; Kjær, A.; Kastrup, J. Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: Effect on cell proliferation and differentiation. Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 1171-1177.
134. Gildehaus, F.J.; Haasters, F.; Drosse, I.; Wagner, E.; Zach, C.; Mutschler, W.; Cumming, P.; Bartenstein, P.; Schieker, M. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol. Imaging Biol. 2011, 13, 1204-1214.
135. Hu, S.L.; Lu, P.G.; Zhang, L.J.; Li, F.; Chen, Z.; Wu, N.; Meng, H.; Lin, J.K.; Feng, H. In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells. J. Cell. Biochem. 2012, 113, 1005-1012.
136. Arbab, A.S.; Yocum, G.T.; Kalish, H.; Jordan, E.K.; Anderson, S.A.; Khakoo, A.Y.; Read, E.J.; Frank, J.A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104, 1217-1223.
137. Bulte, J.; Walczak, P.; Bernard, S.; Gleich, B.; Weizenecker, J.; Borgert, J.; Aerts, H.; Boeve, H. Magnetic Nanoparticles: Particle Science, Imaging Technology, and Clinical Applications: Proceedings of the First International Workshop on Magnetic Particle Imaging. In Developing Cellular MPI: Initial Experience; World Scientific Publishing Company: Singapore, Singapore, 2010; pp. 201-204.
138. Neoh, K.G.; Kang, E.T. Surface modification of magnetic nanoparticles for stem cell labeling. Soft Matter 2012, 8, 2057-2069.
139. Babic, M.; Horák, D.; Trchová, M.; Jendelová, P.; Glogarová, K.; Lesný, P.; Herynek, V.; Hájek, M.; Syková, E. Poly (L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjugate Chem. 2008, 19, 740-750.
140. Thorek, D.L.J.; Tsourkas, A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008, 29, 3583-3590.
141. Jo, J.I.; Aoki, I.; Tabata, Y. Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells. J. Control. Release 2010, 142, 465-473.
142. Jiang, X.; Dausend, J.; Hafner, M.; Musyanovych, A.; Röcker, C.; Landfester, K.; Mailänder, V.; Nienhaus, G.U. Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 2010, 11, 748-753.
143. Shi, Z.; Neoh, K.G.; Kang, E.T.; Shuter, B.; Wang, S.C.; Poh, C.; Wang, W. (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells. ACS Appl. Mater. Interfaces 2009, 1, 328-335.
144. Jander, S.; Schroeter, M.; Saleh, A. Imaging inflammation in acute brain ischemia. Stroke 2007, 38, 642-645.
145. Rudd, J.H.F.; Hyafil, F.; Fayad, Z.A. Inflammation imaging in atherosclerosis. Arterioscl. Throm. Vas. 2009, 29, 1009-1016.
146. Smirnov, P.; Poirier-Quinot, M.; Wilhelm, C.; Lavergne, E.; Ginefri, J.C.; Combadière, B.; Clément, O.; Darrasse, L.; Gazeau, F. In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 tesla MRI system. Magnet. Reson. Med. 2008, 60, 1292-1297.
147. Hu, D.E.; Kettunen, M.I.; Brindle, K.M. Monitoring T-lymphocyte trafficking in tumors undergoing immune rejection. Magnet. Reson. Med. 2005, 54, 1473-1479.
148. Wuerfel, E.; Smyth, M.; Millward, J.M.; Schellenberger, E.; Glumm, J.; Prozorovski, T.; Aktas, O.; Schulze-Topphoff, U.; Schnorr, J.; Wagner, S., et al. Electrostatically stabilized magnetic nanoparticles-An optimized protocol to label murine T Cells for in vivo MRI. Front. Neurol. 2011, 2, 72:1-72:9.
149. Rauwerdink, A.M.; Weaver, J.B. Viscous effects on nanoparticle magnetization harmonics. J. Magn. Magn. Mater. 2010, 322, 609-613.
150. Rauwerdink, A.M.; Weaver, J.B. Measurement of molecular binding using the brownian motion of magnetic nanoparticle probes. Appl. Phys. Lett. 2010, 96, 033702:1-033702:3.
151. Gleich, B.; Weizenecker, J.; Borgert, J. Theory, simulation and experimental results of the acoustic detection of magnetization changes in superparamagnetic iron oxide. BMC Med. Imaging 2011, 11, 16:1-16:6.